Mahendra Rao

Apr 13, 2006

Premium

Invitrogen has named former NIH stem cell section chief Mahendra Rao vice president of research of its Stem Cells and Regenerative Medicine business.

Rao holds an MD from Bombay University in India and a PhD in developmental neurobiology from the California Institute of Technology.

Filed under

Gene Silencing/Gene Editing

RNAi

Breaking News

Illumina Acquires IDbyDNA
Molecular Tumor Profiling Benefits Pediatric Cancer Patients, Study Finds
People in the News at Congenica, Proof Diagnostics, Burning Rock Biotech, More
New Products Posted to GenomeWeb: Illumina, Yourgene Health, Meridian Bioscience
In Brief This Week: Strata Oncology, University of Maryland Medicine, Helio Health, More

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.